The U.S. Department of Justice (“DOJ”) and the U.S. Department of Health and Human Services (“HHS”) have announced the formation of a newly strengthened False Claims Act (“FCA”) Working Group, signaling a more coordinated and...more
On May 12, 2025, the U.S. Department of Justice’s Criminal Division unveiled an overhaul of its white-collar enforcement policies in a memo issued by Matthew Galeotti, head of the Criminal Division. The memo, titled “Focus,...more
5/16/2025
/ Corporate Crimes ,
Corporate Governance ,
Corporate Misconduct ,
Department of Justice (DOJ) ,
Enforcement Actions ,
Enforcement Priorities ,
Fraud ,
Government Investigations ,
Healthcare Fraud ,
Investigations ,
Voluntary Disclosure ,
Whistleblowers ,
White Collar Crimes
In this episode, Mike Burke, AGG Corporate partner and co-chair of the firm’s International practice, is joined by David Blank, AGG Healthcare partner, to discuss how foreign life sciences companies can proactively address...more
On January 23, 2025, the U.S. Court of Appeals for the Fourth Circuit affirmed a federal district court’s ruling against the Pharmaceutical Coalition for Patient Access (“Coalition”), rejecting its challenge to an unfavorable...more